CDC and FDA this week said the romaine lettuce linked to an outbreak of E. coli is no longer available for sale, in today's bite-sized hospital and health industry news from Arizona, Tennessee, and Texas.
The United States today allocates more of its economic resources toward health care than any other country, and the country fares far worse on several health outcomes than a number of peer countries—but this wasn't always the case, Austin Frakt writes for the New York Times' "The Upshot." Here's what experts think might explain the divergence.
A small but growing number of hospitals—including Brigham and Women's Hospital and Mount Sinai—are providing in-home treatment for patients who present at the ED with conditions that would typically merit hospitalization.
Data from the third annual end-of-life care survey by the University of Massachusetts Medical School show Massachusetts is starting to see "the first signs of real change," according to Atul Gawande, co-chair of the Massachusetts Coalition for Serious Illness Care.
FDA on Thursday approved the first in a new class of drugs designed to prevent migraines in adults—a move that some providers said could revolutionize patient care.
HHS Secretary Alex Azar, whose department must sign off on Vermont's drug importation plan, has been critical of proposals to allow drug imports from Canada and other foreign countries.
What CDC wants you to know before you take dip in the hotel swimming pool, a new form of synesthesia makes its debut, and more, in our reading list for your weekend.
